While Zymeworks BC Inc has overperformed by 7.43%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ZYME rose by 127.54%, with highs and lows ranging from $15.63 to $6.83, whereas the simple moving average jumped by 56.64% in the last 200 days.
On Nov-08-24, Leerink Partners Upgraded Zymeworks BC Inc (NASDAQ: ZYME) to Outperform. A report published by Wells Fargo on November 01, 2024, Downgraded its rating to ‘Equal Weight’ for ZYME. Wells Fargo also rated ZYME shares as ‘Overweight’, setting a target price of $12 on the company’s shares in an initiating report dated March 21, 2023. H.C. Wainwright Reiterated the rating as Neutral on January 04, 2023, but set its price target from $10 to $8. Jefferies December 20, 2022d its ‘Hold’ rating to ‘Buy’ for ZYME, as published in its report on December 20, 2022. H.C. Wainwright’s report from November 01, 2022 suggests a price prediction of $8 for ZYME shares, giving the stock a ‘Neutral’ rating. SVB Leerink also rated the stock as ‘Mkt Perform’.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Analysis of Zymeworks BC Inc (ZYME)
Further, the quarter-over-quarter decrease in sales is -3.07%, showing a negative trend in the upcoming months.
One of the most important indicators of Zymeworks BC Inc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of -28.73% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 4.10, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and ZYME is recording 643.50K average volume. On a monthly basis, the volatility of the stock is set at 4.20%, whereas on a weekly basis, it is put at 7.78%, with a gain of 22.41% over the past seven days. Furthermore, long-term investors anticipate a median target price of $17.29, showing growth from the present price of $16.77, which can serve as yet another indication of whether ZYME is worth investing in or should be passed over.
How Do You Analyze Zymeworks BC Inc Shares?
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 2.31%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 99.62% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
ZYME shares are owned by institutional investors to the tune of 99.62% at present.
